The GLP-1 and glucagon receptor dual agonist cotadutide significantly reduced hepatic steatosis, inflammation, and fibrosis in NASH male mice on a high fructose, trans-fat, and cholesterol diet [195]. This evidence concerns the gene GLP1R and Hepatic steatosis.